Hyderabad 13th March 2025: NephroPlus, Asia’s largest dialysis care network, has achieved a monumental milestone by setting a Guinness World Record for the ‘Most Number of Sign-ups for a Health Screening Test in One Week’ with 10,500 sign-ups within the period – 6th – 11th March 2025 and securing a place in the India Book of Records for the ‘Maximum People Screened for Serum Creatinine Test Held at Multiple Venues.’ Over 4500 screenings were conducted from March 6th to 8th, 2025, across 26+ cities as part of its campaign for World Kidney Day 2025, with additional screenings to be carried out in the following days. This groundbreaking initiative aimed to promote awareness about the early detection and prevention of Chronic Kidney Disease (CKD) and educate communities on essential kidney health practices through accessible screenings and personalized risk assessments.
The free kidney screening camps, organized under the slogan ‘Are Your Kidneys OK? Detect Early and Protect Kidney Health,’ received an overwhelming response from thousands of participants. The initiative specifically targeted high-risk individuals, including those with diabetes and hypertension, emphasizing the critical importance of early detection in preventing kidney disease. Major cities covered in the campaign included Bengaluru, Delhi, Jaipur, Pune, Hyderabad, Lucknow, and Ranchi among others.
On this occasion, NephroPlus also launched a groundbreaking study on Chronic Kidney Disease (CKD). With the extensive offline data collected through these screenings, the company plans to publish a white paper and a manuscript in a reputed academic journal—most likely the first-ever global white paper on CKD prevention. This marks a significant milestone in the global fight against CKD and reinforces NephroPlus’s leadership in kidney health innovation.
Vikram Vuppala, Group CEO and Founder of NephroPlus said: “This remarkable accomplishment highlights our unwavering commitment to raising awareness about kidney health in a country where CKD prevalence ranges from 12% to 21% across different regions. Many cases remain undiagnosed until the advanced stages, which underscores the need for large-scale, preventive health interventions. Setting two world records simultaneously reflects the unprecedented scale of our initiative and our determination to bring life-saving early detection to communities with limited access to specialized healthcare.” He further added: “The launch of our CKD prevention study is a game-changer. Governments worldwide need to recognize that CKD prevention is not just a health initiative—it’s a strategic economic investment. The insights from this study will drive advocacy for increased government funding and policy changes focused on early detection and intervention. We believe this could have a lasting impact on global healthcare frameworks.”
The CKD white paper will emphasize why governments should prioritize CKD prevention, not only as a public health measure but also as a long-term economic strategy. Early intervention can reduce healthcare costs, prevent productivity loss, and improve the overall quality of life for millions. This pioneering research sets NephroPlus apart as the global leader in CKD prevention and treatment innovation.
Building on this achievement, NephroPlus plans to further its kidney health awareness efforts in the upcoming years. The insights gathered from this campaign will contribute to further research and advocacy efforts, ensuring greater access to early diagnosis and preventive care for millions across India.